CRIS Current Research Information System

ZUFFA, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.431
EU - Europa 1.145
AS - Asia 657
AF - Africa 82
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
SA - Sud America 2
Totale 3.323
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.419
GB - Regno Unito 348
VN - Vietnam 232
SE - Svezia 209
CN - Cina 194
DE - Germania 146
SG - Singapore 136
IT - Italia 128
UA - Ucraina 77
IN - India 56
FR - Francia 51
IE - Irlanda 51
RU - Federazione Russa 41
TG - Togo 30
EE - Estonia 27
ZA - Sudafrica 24
NG - Nigeria 17
BG - Bulgaria 14
JO - Giordania 14
BE - Belgio 12
CA - Canada 12
FI - Finlandia 11
CI - Costa d'Avorio 8
CH - Svizzera 7
JP - Giappone 7
NL - Olanda 6
GR - Grecia 4
IR - Iran 4
EU - Europa 3
HK - Hong Kong 3
HR - Croazia 3
RO - Romania 3
SC - Seychelles 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
LV - Lettonia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BR - Brasile 1
CL - Cile 1
KG - Kirghizistan 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
UZ - Uzbekistan 1
Totale 3.323
Salva come PNG Salva come JPEG
Città #
Southend 322
Dong Ket 201
Chandler 179
Singapore 118
Fairfield 117
Ashburn 99
Ann Arbor 92
Seattle 70
Wilmington 70
Houston 67
Woodbridge 66
Princeton 58
Dublin 51
Jacksonville 47
Boardman 43
Cambridge 42
Santa Clara 41
Beijing 31
New York 31
Lomé 30
Padova 30
Westminster 29
Nanjing 26
Bologna 22
Medford 22
Berlin 19
Jinan 18
Abeokuta 17
Amman 14
Milan 14
Sofia 14
Saint Petersburg 13
Brussels 12
Changsha 11
Bremen 10
Helsinki 10
Hebei 9
Abidjan 8
Jiaxing 7
Redwood City 7
Toronto 7
Falls Church 6
Nanchang 6
Paris 6
Romainville 6
Shenyang 6
Tokyo 6
Turin 6
Bühl 5
Mountain View 5
Mülheim 5
San Diego 5
Bern 4
Dearborn 4
Guangzhou 4
Hangzhou 4
Los Angeles 4
Norwalk 4
Verona 4
Zhengzhou 4
Andover 3
Chengdu 3
Florence 3
Kunming 3
Leawood 3
Mahé 3
Ningbo 3
Shanghai 3
Taizhou 3
Tianjin 3
Winnipeg 3
Dubai 2
Faenza 2
Frankfurt Am Main 2
Fuzhou 2
Hanover 2
Hong Kong 2
Hyderabad 2
Jiangmen 2
Kilburn 2
Moscow 2
Muizenberg 2
Olalla 2
Parma 2
Phoenix 2
Redmond 2
Riga 2
Riva 2
Rome 2
Sacramento 2
San Francisco 2
Shijiazhuang 2
Taiyuan 2
Wuhan 2
Xi'an 2
Zanjan 2
Aarau 1
Albany 1
Amsterdam 1
Ancona 1
Totale 2.275
Salva come PNG Salva come JPEG
Nome #
Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50 221
Alterations of BRCA1 and PALB2 Define a Novel Class of Complex-Karyotype AML with a Very Bad Prognosis 172
Co-occurrence of alterations in the DNA damage repair genes synergize with uncontrolled proliferation and associate with very-poor prognosis in acute myeloid leukemia patients 169
A cell cycle-related genomic and transcriptomic signature distinguish aneuploid and euploid acute myeloid leukemia 159
Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities 148
Apoptotic death of Bcr-Abl-expressing myeloid progenitors in response to the m-Tor inhibitor RAD001 (Everolimus) is promoted by the nuclear import of c-Abl 139
P210 Bcr-abl tyrosine kinase interaction with histone deacetylase 1 modifies histone H4 acetylation and chromatin structure of chronic myeloid leukaemia haematopoietic progenitors 130
Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients 129
The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study 126
Two or More Chemotherapy Consolidation Courses, Followed By Autologous Bone Marrow Transplantation, and MRD Negativity, Give Long Term Overall Survival in Acute Myeloid Leukemia Patients 124
Novel Genomic Patterns of Metabolic Remodeling in Acute Myeloid Leukemia 122
Very Poor Outcome and Chemoresistance of Acute Myeloid Leukemia Patients with TP53 Mutations: Correlation with Complex Karyotype and Clinical Outcome 122
Gemtuzumab-Ozogamicin Containing Regimens As Induction Therapy Give the Highest Complete Remission Rate and the Longest Overall Survival Compared with Other Induction Regimens in Patients with Newly Diagnosed Acute Myeloid Leukemia 120
Survival analysis of patients carrying different FLT3 mutations (internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations) in 459 consecutive non M3 newly diagnosed acute myeloid leukemia (AML) 119
Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI606 110
Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients 109
NEW STRATEGIES IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA. COMBINED USE OF SRC AND TYROSINE KINASE INHIBITORS CIRCUMVENTS THE DEVELOPMENT OF DRUG-RESISTANCE 108
HDAC1 (histone deacetylase1) involvement in Chronic Myeloid Leukemia 101
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 96
Genomic instability in the development of non-Hodgkin lymphomas secondary to Hodgkin lymphoma 93
Genomic imbalances associated with secondary acute leukemias in Hodgkin lymphoma. 93
Evaluation of the Diasorin Q-Lamp technology for the molecular diagnosis of the philadelphia positive leukemias: an italian multicenter study 92
Survival analysis of 409 consecutive patients with newly diagnosed acute myeloid leukemia treated with intensive induction therapy, with or without the addition of gemtuzomab-ozagomicin (GO) 91
Very poor outcome and chemoresistance of acute myeloid leukemia patients with TP53 mutations: Correlation with complex karyotype and clinical outcome 87
Specific chromosomic alterations confer therapy resistance in a cohort of 49 patients with newly diagnosed acute myeloid leukemia treated with intensive chemotherapy 86
Ultra-Deep Sequencing Strategy Is a Precious Tool to Find Small Clones Harbouring FLT3 Mutations in AML Patients 84
The m-TOR inhibitor everolimus complements pro-apoptotic and anti-proliferative effects of imatinib on chronic myeloid leukemia progenitors by promoting the nuclear import of normal c-Abl protein 83
Post-translational modifications of FOXO3a transcription factor associated with the constitutive tyrosine kinase activity of p210 BCR-ABL protein. Implications for new targeted therapies 82
P210 BCR-ABL tyrosine kinase prevents apoptotic cell death through multiple pathways converging at mitochondrial membranes 82
Totale 3.397
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.817
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.817
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020418 0 0 0 0 0 57 75 85 77 50 40 34
2020/2021591 79 23 5 23 11 27 22 26 38 25 33 279
2021/2022592 31 15 36 66 55 32 16 26 27 41 124 123
2022/2023710 98 97 47 90 50 58 15 35 116 22 50 32
2023/2024193 4 31 5 34 14 53 14 9 7 8 7 7
2024/2025317 11 102 57 51 75 21 0 0 0 0 0 0
Totale 3.397